| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/22/2023 | 7.98% | UBS | $95 → $85 | Maintains | Neutral |
| 10/04/2023 | 20.68% | Raymond James | $100 → $95 | Maintains | Strong Buy |
| 09/18/2023 | 24.49% | Citigroup | $98 → $98 | Maintains | Buy |
| 09/14/2023 | 9.25% | Evercore ISI Group | $91 → $86 | Maintains | Outperform |
| 09/11/2023 | 15.6% | Evercore ISI Group | $94 → $91 | Maintains | Outperform |
| 07/28/2023 | 27.03% | Raymond James | $102 → $100 | Maintains | Strong Buy |
| 07/24/2023 | 29.57% | Raymond James | $101 → $102 | Maintains | Strong Buy |
| 05/23/2023 | 14.33% | Citigroup | $80 → $90 | Maintains | Buy |
| 04/24/2023 | 2.9% | Keefe, Bruyette & Woods | $90 → $81 | Maintains | Market Perform |
| 04/11/2023 | 14.33% | Goldman Sachs | $103 → $90 | Maintains | Buy |
| 04/10/2023 | 14.33% | Goldman Sachs | $103 → $90 | Maintains | Buy |
| 03/28/2023 | 1.63% | Citigroup | $100 → $80 | Maintains | Buy |
| 03/03/2023 | 13.06% | JP Morgan | $80 → $89 | Maintains | Neutral |
| 01/27/2023 | 27.03% | Citigroup | → $100 | Initiates Coverage On | → Buy |
| 01/27/2023 | 11.79% | Keefe, Bruyette & Woods | → $88 | Downgrades | Outperform → Market Perform |
| 01/20/2023 | 28.3% | Raymond James | $105 → $101 | Maintains | Strong Buy |
| 10/20/2022 | 33.38% | Raymond James | $113 → $105 | Maintains | Strong Buy |
| 10/19/2022 | 11.79% | Goldman Sachs | $98 → $88 | Maintains | Buy |
| 08/05/2022 | 43.55% | Raymond James | $110 → $113 | Maintains | Strong Buy |
| 07/22/2022 | 39.74% | Raymond James | $122 → $110 | Upgrades | Outperform → Strong Buy |
| 05/06/2022 | 54.98% | Raymond James | $111 → $122 | Maintains | Outperform |
| 04/26/2022 | 41.01% | Raymond James | $126 → $111 | Maintains | Outperform |
| 03/10/2022 | 47.36% | Wolfe Research | $171 → $116 | Maintains | Outperform |
| 02/25/2022 | 60.06% | Raymond James | $124 → $126 | Maintains | Outperform |
| 01/21/2022 | 57.52% | Raymond James | $118 → $124 | Maintains | Outperform |
| 11/23/2021 | 46.09% | Keefe, Bruyette & Woods | → $115 | Upgrades | Market Perform → Outperform |
| 10/22/2021 | 37.2% | Raymond James | $103 → $108 | Maintains | Outperform |
| 07/30/2021 | 30.84% | Raymond James | $93 → $103 | Maintains | Outperform |
| 06/15/2021 | 42.28% | Wolfe Research | → $112 | Initiates Coverage On | → Outperform |
| 04/30/2021 | 18.14% | Raymond James | $89 → $93 | Maintains | Outperform |
| 04/27/2021 | 13.06% | Raymond James | $82 → $89 | Maintains | Outperform |
| 01/22/2021 | -11.08% | Raymond James | $59 → $70 | Maintains | Outperform |
| 11/02/2020 | -31.4% | UBS | $47 → $54 | Maintains | Neutral |
| 10/30/2020 | -25.05% | Raymond James | $55 → $59 | Maintains | Outperform |
| 08/11/2020 | -40.29% | UBS | $41 → $47 | Maintains | Neutral |
| 07/29/2020 | -32.67% | Raymond James | $57 → $53 | Maintains | Outperform |
| 05/13/2020 | -47.92% | UBS | $59 → $41 | Maintains | Neutral |
| 05/08/2020 | -55.54% | CFRA | $57 → $35 | Downgrades | Hold → Sell |
| 05/08/2020 | -35.21% | Keefe, Bruyette & Woods | $52 → $51 | Maintains | Market Perform |
| 04/09/2020 | — | JP Morgan | Downgrades | Overweight → Neutral | |
| 02/28/2020 | -25.05% | UBS | $57 → $59 | Maintains | Neutral |
| 01/24/2020 | -8.54% | Raymond James | → $72 | Downgrades | Strong Buy → Outperform |
| 11/26/2019 | -21.24% | B of A Securities | → $62 | Reinstates | → Buy |
| 08/12/2019 | -27.59% | UBS | $56 → $57 | Maintains | Neutral |
| 08/02/2019 | -14.89% | Raymond James | $65 → $67 | Maintains | Strong Buy |
| 07/11/2019 | -31.4% | Compass Point | → $54 | Initiates Coverage On | → Neutral |
| 01/03/2019 | — | B of A Securities | Downgrades | Buy → Neutral |
What is the target price for CBRE Group (CBRE)?
The latest price target for CBRE Group (NYSE: CBRE) was reported by UBS on November 22, 2023. The analyst firm set a price target for $85.00 expecting CBRE to rise to within 12 months (a possible 7.98% upside). 16 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for CBRE Group (CBRE)?
The latest analyst rating for CBRE Group (NYSE: CBRE) was provided by UBS, and CBRE Group maintained their neutral rating.
When is the next analyst rating going to be posted or updated for CBRE Group (CBRE)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of CBRE Group, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for CBRE Group was filed on November 22, 2023 so you should expect the next rating to be made available sometime around November 22, 2024.
Is the Analyst Rating CBRE Group (CBRE) correct?
While ratings are subjective and will change, the latest CBRE Group (CBRE) rating was a maintained with a price target of $95.00 to $85.00. The current price CBRE Group (CBRE) is trading at is $78.72, which is out of the analyst's predicted range.